TGTX
TG Therapeutics Inc
NASDAQ: TGTX · HEALTHCARE · BIOTECHNOLOGY
$57.40
+1.70% today
Updated 2026-10-28
Market cap
$8.26B
P/E ratio
19.63
P/S ratio
10.33x
EPS (TTM)
$2.75
Dividend yield
—
52W range
$27 – $59
Volume
1.8M
TG Therapeutics Inc (TGTX) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$57.40
12-Month target
$30.20
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.2B | $0.3B | $0.6B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 19.63x (capped 25x) · Margin: 55.20%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.